Literature DB >> 20857305

Functional significance of the intermediate conductance Ca2+-activated K+ channel for the short-term survival of injured erythrocytes.

Michael Föller1, Diwakar Bobbala, Saisudha Koka, Krishna M Boini, Hasan Mahmud, Ravi S Kasinathan, Ekaterina Shumilina, Kerstin Amann, Golo Beranek, Ulrike Sausbier, Peter Ruth, Matthias Sausbier, Florian Lang, Stephan M Huber.   

Abstract

Increased cytosolic Ca(2+) concentrations activate Gardos K(+) channels in human erythrocytes with membrane hyperpolarization, efflux of K(+), Cl⁻, and osmotically obliged H₂O resulting in cell shrinkage, a phenomenon referred to as Gardos effect. We tested whether the Gardos effect delays colloid osmotic hemolysis of injured erythrocytes from mice lacking the Ca(2+)-activated K(+) channel K(Ca)3.1. To this end, we applied patch clamp and flow cytometry and determined in vitro as well as in vivo hemolysis. As a result, erythrocytes from K(Ca)3.1-deficient (K(Ca)3.1(-/-)) mice lacked Gardos channel activity and the Gardos effect. Blood parameters, reticulocyte count, or osmotic erythrocyte resistance, however, did not differ between K(Ca)3.1(-/-) mice and their wild-type littermates, suggesting low or absent Gardos channel activity in unstressed erythrocytes. Oxidative stress-induced Ca(2+) entry and phospholipid scrambling were significantly less pronounced in K(Ca)3.1(-/-) than in wild-type erythrocytes. Moreover, in vitro treatment with α-toxin from Staphylococcus aureus, which forms pores in the cellular membrane, resulted in significantly stronger hemolysis of K(Ca)3.1(-/-) than of wild-type erythrocytes. Intravenous injection of α-toxin induced more profound hemolysis in K(Ca)3.1(-/-) than in wild-type mice. Similarly, intra-peritoneal application of the redox-active substance phenylhydrazine, an agent for the induction of hemolytic anemia, was followed by a significantly stronger decrease of hematocrit in K(Ca)3.1(-/-) than in wild-type mice. Finally, malaria infection triggered the activation of K(Ca)3.1 and transient shrinkage of the infected erythrocytes. In conclusion, K(Ca)3.1 channel activity and Gardos effect counteract hemolysis of injured erythrocytes, thus decreasing hemoglobin release into circulating blood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20857305     DOI: 10.1007/s00424-010-0878-1

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  87 in total

Review 1.  Eryptosis, a window to systemic disease.

Authors:  Florian Lang; Erich Gulbins; Holger Lerche; Stephan M Huber; Daniela S Kempe; Michael Foller
Journal:  Cell Physiol Biochem       Date:  2008-12-09

2.  Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria.

Authors:  D Bratosin; J Estaquier; F Petit; D Arnoult; B Quatannens; J P Tissier; C Slomianny; C Sartiaux; C Alonso; J J Huart; J Montreuil; J C Ameisen
Journal:  Cell Death Differ       Date:  2001-12       Impact factor: 15.828

3.  Staphylococcus aureus alpha-toxin. 1. Effect on protein phosphorylation in myelin.

Authors:  K F Chan; P Lazarovici
Journal:  Toxicon       Date:  1987       Impact factor: 3.033

4.  Suicidal erythrocyte death in sepsis.

Authors:  Daniela S Kempe; Ahmad Akel; Philipp A Lang; Tobias Hermle; Raja Biswas; Juliana Muresanu; Björn Friedrich; Peter Dreischer; Christiane Wolz; Ulrike Schumacher; Andreas Peschel; Friedrich Götz; Gerd Döring; Thomas Wieder; Erich Gulbins; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2006-12-16       Impact factor: 4.599

5.  Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.

Authors:  Ivica Grgic; Eva Kiss; Brajesh P Kaistha; Christoph Busch; Michael Kloss; Julia Sautter; Anja Müller; Anuradha Kaistha; Claudia Schmidt; Girija Raman; Heike Wulff; Frank Strutz; Hermann-Josef Gröne; Ralf Köhler; Joachim Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-13       Impact factor: 11.205

6.  Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4.

Authors:  Ted Begenisich; Tesuji Nakamoto; Catherine E Ovitt; Keith Nehrke; Carlo Brugnara; Seth L Alper; James E Melvin
Journal:  J Biol Chem       Date:  2004-09-03       Impact factor: 5.157

7.  Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis.

Authors:  Marianne Skals; Niklas R Jorgensen; Jens Leipziger; Helle A Praetorius
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

8.  Single Ca(2+)-activated K+ channels in human erythrocytes: Ca2+ dependence of opening frequency but not of open lifetimes.

Authors:  T Leinders; R G van Kleef; H P Vijverberg
Journal:  Biochim Biophys Acta       Date:  1992-11-23

9.  Induction of suicidal erythrocyte death by listeriolysin from Listeria monocytogenes.

Authors:  Michael Föller; Ekaterina Shumilina; Rebecca Lam; Walid Mohamed; Ravi Kasinathan; Stephan Huber; Trinad Chakraborty; Florian Lang
Journal:  Cell Physiol Biochem       Date:  2007-10-30

10.  Abolition of Ca2+-mediated intestinal anion secretion and increased stool dehydration in mice lacking the intermediate conductance Ca2+-dependent K+ channel Kcnn4.

Authors:  Carlos A Flores; James E Melvin; Carlos D Figueroa; Francisco V Sepúlveda
Journal:  J Physiol       Date:  2007-06-21       Impact factor: 5.182

View more
  11 in total

1.  Trpc2 depletion protects red blood cells from oxidative stress-induced hemolysis.

Authors:  Iwona Hirschler-Laszkiewicz; Wenyi Zhang; Kerry Keefer; Kathleen Conrad; Qin Tong; Shu-jen Chen; Sarah Bronson; Joseph Y Cheung; Barbara A Miller
Journal:  Exp Hematol       Date:  2011-09-14       Impact factor: 3.084

2.  P2X receptor stimulation amplifies complement-induced haemolysis.

Authors:  J L Hejl; M Skals; J Leipziger; H A Praetorius
Journal:  Pflugers Arch       Date:  2012-11-14       Impact factor: 3.657

3.  Differential role of IK and BK potassium channels as mediators of intrinsic and extrinsic apoptotic cell death.

Authors:  Michael B McFerrin; Kathryn L Turner; Vishnu Anand Cuddapah; Harald Sontheimer
Journal:  Am J Physiol Cell Physiol       Date:  2012-09-19       Impact factor: 4.249

4.  Haemolysis induced by α-toxin from Staphylococcus aureus requires P2X receptor activation.

Authors:  Marianne Skals; Jens Leipziger; Helle A Praetorius
Journal:  Pflugers Arch       Date:  2011-08-17       Impact factor: 3.657

5.  Inhibition of cation channels in human erythrocytes by spermine.

Authors:  Yuliya V Kucherenko; Florian Lang
Journal:  J Membr Biol       Date:  2010-11-10       Impact factor: 1.843

6.  The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity.

Authors:  Venée N Tubman; Pedro Mejia; Boris E Shmukler; Amy K Bei; Seth L Alper; James R Mitchell; Carlo Brugnara; Manoj T Duraisingh
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

Review 7.  Ion Transport and Radioresistance.

Authors:  Bastian Roth; Stephan M Huber
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

8.  'Gardos Channelopathy': a variant of hereditary Stomatocytosis with complex molecular regulation.

Authors:  Elisa Fermo; Anna Bogdanova; Polina Petkova-Kirova; Anna Zaninoni; Anna Paola Marcello; Asya Makhro; Pascal Hänggi; Laura Hertz; Jens Danielczok; Cristina Vercellati; Nadia Mirra; Alberto Zanella; Agostino Cortelezzi; Wilma Barcellini; Lars Kaestner; Paola Bianchi
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

Review 9.  KCa3.1 Channels and Glioblastoma: In Vitro Studies.

Authors:  Lukas Klumpp; Efe C Sezgin; Marco Skardelly; Franziska Eckert; Stephan M Huber
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

10.  P2X receptor-dependent erythrocyte damage by α-hemolysin from Escherichia coli triggers phagocytosis by THP-1 cells.

Authors:  Steen K Fagerberg; Marianne Skals; Jens Leipziger; Helle A Praetorius
Journal:  Toxins (Basel)       Date:  2013-03-05       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.